Maria Sharapova has failed a drugs doping test at the Australian Open. Changes in regulations mean meldonium, once a prescription drug taken by the athlete, has now been banned
Unless the pharmaceutical industry manages product lifecycle data holistically in 2016, companies’ ability to achieve regulatory compliance and maintain speed to market will be compromised, warns Mark Evenepoel, Group, Amplexor Life Sciences
Over the past few years, the industry has experienced significant regulatory change and looking to the future, the strict nature of the industry doesn’t appear to be slacking.
Martyn Williams, MD, Copa-Data UK, opens up on the road to compliance
The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a campaign highlighting the work pharmaceutical assessors do and the difference they make to public health
Robert Donnell, Durbin, specialist distributor of pharmaceuticals, medical and relief supplies, examines the increasing prevalence of managed access programmes and the challenges faced in getting the most appropriate drug to the patient in time
